The Supreme Court ruling in Harrington v Purdue Pharma restricts the use of bankruptcy as a shield in public harm litigation, signaling increased accountability for corporations. This decision follows the temporary injunctive relief for nondebtors in bankruptcy court post-Purdue Pharma. The Sackler family, associated with Purdue Pharma, received a break at the Supreme Court, while the Department of Defense was judged to have sovereign immunity in a related case.